These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16472703)

  • 21. Non-small cell lung cancer: second-line and beyond.
    Stahel RA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x97-100. PubMed ID: 17018760
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of advanced non-small cell lung cancer: current trends.
    Haura EB
    Curr Opin Pulm Med; 2002 Jul; 8(4):251-6. PubMed ID: 12055385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The study progress of second-line chemotherapy of small cell lung cancer.].
    Miao Q; Jiang L
    Zhongguo Fei Ai Za Zhi; 2008 Aug; 11(4):591-4. PubMed ID: 20735977
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status and progress in treatment of non-small cell lung cancer].
    Liao M; Zhao Y
    Zhongguo Fei Ai Za Zhi; 2001 Jun; 4(3):161-4. PubMed ID: 21047467
    [No Abstract]   [Full Text] [Related]  

  • 25. Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future.
    Park K
    Cancer Res Treat; 2003 Aug; 35(4):279-80. PubMed ID: 26680947
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-small cell lung cancer: the challenges of the next decade.
    Le Chevalier T
    Front Oncol; 2011; 1():29. PubMed ID: 22649759
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing therapy in previously treated non-small cell lung cancer.
    Miller VA
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S25-31. PubMed ID: 16472706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-line treatment options in advanced non-small cell lung cancer: current status.
    Cullen M
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S3-8. PubMed ID: 16472703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of novel second-line targeted therapies in non-small cell lung cancer.
    Massarelli E; Herbst RS
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S9-16. PubMed ID: 16472704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).
    Reck M
    Anticancer Res; 2005; 25(3A):1501-6. PubMed ID: 16033051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
    Galetta D; Rossi A; Colucci G; Gebbia V
    Oncology; 2009; 77 Suppl 1():113-21. PubMed ID: 20130439
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.